Trials / Completed
CompletedNCT04016025
A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers
Randomized Single-blind Study on the Adherence to Treatment With Topical Methylprednisolone Aceponate (Advantan®) in Different Vehicles (AD-HERE)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Jena University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Untersuchung der Adhärenz zur topischen Standardtherapie bei Patienten mit chronischem Handekzem in Abhängigkeit von der Galenik
Detailed description
Prospective, randomized, parallel grouped, single-blinded (investigator), monocentric objective assessment of the adherence to the treatment with topical methylprednisolone aceponate (Advantan®) depending on the type of vehicle in patients with hand eczema treated according to the current Guideline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Adherence to topical standard therapy assessed | Adherence defined as percentage of patients applying at least aimed daily dose |
Timeline
- Start date
- 2020-12-02
- Primary completion
- 2022-03-11
- Completion
- 2022-04-14
- First posted
- 2019-07-11
- Last updated
- 2022-05-10
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04016025. Inclusion in this directory is not an endorsement.